The Single Best Pot Stock to Buy in October

If you can take the wait, this pot stock could be well worth it in the next decade or more, even with shares down 70% this year alone.

| More on:
A cannabis plant grows.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

October seems like a really good time to discuss the best pot stock, doesn’t it? After all, it wasn’t long ago that October saw pot stocks in general reach their peak. Back in 2018, on the event of legalization, it seemed like we couldn’t do wrong when it came to cannabis stocks.

But by the next day, it turns out we certainly could. Pot stocks fell significantly, leading to a drop that continues to this day. And in this current economic environment, it certainly doesn’t look like it’ll be improving anytime soon.

However, if you were a smart investor, you would have bought up a pot stock as a long-term hold. With that in mind, right now stinks, sure. But over time the right pot stock will still lead you to significant gains.

How can you say that?

It’s true, looking back over the last few years, most any pot stock you came across has likely performed poorly. But let’s be real here. Cannabis use isn’t going anywhere. Governments around the world are moving towards legal use, or at least decriminalization. This has already occurred in Canada, but what everyone is really waiting on is the United States.

I’m pretty sure if President Joe Biden could, he’d legalize pot tomorrow. Not because I think he’s a stoner, but because it’s a cash cow waiting to be milked! State after state continues to legalize marijuana, and they’re seeing an influx of cash relative to that of alcohol production.

It’s this that makes the future bright for a select few companies. But that means it’s all about choosing the right pot stock. And today, I continue to believe that stock should be Canopy Growth (TSX:WEED)(NASDAQ:CGC).

A pot stock focused on U.S. growth

Canopy Growth stock has been focused on growth in the United States since the beginning. It’s this focus that led to a superb rise, and major partnerships with companies like Constellation Brands. Further, it’s also led to several acquisitions over the past years that should come to fruition under federal legalization in the country.

But this is a long waiting game that has yet to pay dividends. In fact, the company has had to make cost cuts and layoffs, and focus on non-cannabis initiatives to bring in revenue such as its BioSteel brand. So what started as a pure focus, has shifted to a focus on profit.

That’s good for today’s investor who has yet to purchase Canopy Growth stock. The pot stock is now incredibly cheap at just $3.40 per share. That’s a massive decrease from its all-time highs around $70. In 2022, shares are down 70% year to date. Even so, it’s a responsible company if you look at the numbers. It would take just 94.7% of its equity to cover all its debts. That makes it a good buy even at these low levels.

The future is waiting

Federal legalization will happen eventually, if only because of the cash and potential tax revenue that will be generated throughout the country. When that happens, Canopy Growth stock will end its waiting period in the wings and become potentially the world’s largest pot stock in the country with the world’s largest consumption of cannabis. So if you can wait, it could be well worth it, but perhaps only by buying the shares at these insanely low prices.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth Corp. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »